Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Strados Labs has developed the first FDA-cleared wearable biosensor for continuous lung sound monitoring. The RESP® Biosensor enables passive collection of coughs, wheezes, crackles and other lung sounds from hospital to home. It supports decentralized clinical trials by providing objective respiratory endpoints. The device has been validated in multiple studies/abstracts submitted to the American Thoracic Society. Used globally across four continents.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Strados Labs.